Completion of the clinical trial of PacePress® with 122 patients

August 19, 2025

Medinice S.A. has completed the clinical trial of its innovative device PacePress® with a positive outcome of the final analysis.

The study was conducted in Poland in six clinical centers with 122 patients, under a randomized protocol. Participants were randomly assigned to two groups: one group used PacePress®, the other a standard dressing. The analysis showed the Medinice solution’s superiority in minimizing the risk of bleeding complications following CIED implantation. This is a breakthrough moment for the company - the first completed clinical trial in its history, and a key step towards commercializing the product.

Detailed information about the medical device PacePress® can be found under the following link: